The FDA approved a commercial version of a progesterone shot used by women at risk for pre-term birth — but the approval actually makes the drug much harder to get for most patients.
Home : drug approval
Senate report raises questions about FDA after-market review
by healthcarebus February 23, 2010
A new report from the Senate Finance Committee highlights a potential conflict of interest within the FDA — and the safety of one of the world’s top-selling medications.
Connect with Us
Twitter Facebook Google Plus RSS Feed